FDA to Host Joint Meeting of Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Subcommittee

Summary

The US Food and Drug Administration (FDA) will convene a joint meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Subcommittee of the Advisory Committee for Pharmaceutical Science to discuss pharmaceutical science-related matters, as announced in a recent notice.